NL192192C - Farmaceutische preparaten, die menselijk insuline en menselijk C-peptide bevatten. - Google Patents

Farmaceutische preparaten, die menselijk insuline en menselijk C-peptide bevatten. Download PDF

Info

Publication number
NL192192C
NL192192C NL8203315A NL8203315A NL192192C NL 192192 C NL192192 C NL 192192C NL 8203315 A NL8203315 A NL 8203315A NL 8203315 A NL8203315 A NL 8203315A NL 192192 C NL192192 C NL 192192C
Authority
NL
Netherlands
Prior art keywords
human
insulin
peptide
preparation
human insulin
Prior art date
Application number
NL8203315A
Other languages
English (en)
Dutch (nl)
Other versions
NL192192B (nl
NL8203315A (nl
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NL8203315A publication Critical patent/NL8203315A/nl
Publication of NL192192B publication Critical patent/NL192192B/xx
Application granted granted Critical
Publication of NL192192C publication Critical patent/NL192192C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL8203315A 1981-08-27 1982-08-24 Farmaceutische preparaten, die menselijk insuline en menselijk C-peptide bevatten. NL192192C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27
US29671581 1981-08-27

Publications (3)

Publication Number Publication Date
NL8203315A NL8203315A (nl) 1983-03-16
NL192192B NL192192B (nl) 1996-11-01
NL192192C true NL192192C (nl) 1997-03-04

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203315A NL192192C (nl) 1981-08-27 1982-08-24 Farmaceutische preparaten, die menselijk insuline en menselijk C-peptide bevatten.

Country Status (20)

Country Link
JP (1) JPS5846024A (fr)
AU (1) AU551879B2 (fr)
BE (1) BE894185A (fr)
CA (1) CA1176158A (fr)
CH (1) CH650679A5 (fr)
DE (1) DE3232034A1 (fr)
DZ (1) DZ452A1 (fr)
FR (1) FR2513126B1 (fr)
GB (1) GB2104382B (fr)
IE (1) IE54119B1 (fr)
IL (1) IL66611A0 (fr)
IT (1) IT1153182B (fr)
LU (1) LU84359A1 (fr)
MW (1) MW3882A1 (fr)
NL (1) NL192192C (fr)
NZ (1) NZ201682A (fr)
PH (1) PH19361A (fr)
SE (1) SE460334B (fr)
ZA (1) ZA826159B (fr)
ZW (1) ZW17482A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
WO1988002633A1 (fr) * 1986-10-20 1988-04-21 Novo Industri A/S Preparatiosn d'insuline avec du zinc et des protamines
EP0280534B1 (fr) * 1987-02-25 1993-04-21 Novo Nordisk A/S Nouveaux dérivés de l'insuline
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (fr) * 1987-08-14 1991-05-29 Akzo N.V. Préparation pour prévenir ou combattre des complications dans le diabète
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
JP5765813B2 (ja) 2008-09-19 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション 治療用ペプチドのポリマーコンジュゲート
WO2011146518A2 (fr) 2010-05-17 2011-11-24 Cebix Inc. Peptide c pégylé
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CH650679A5 (de) 1985-08-15
SE460334B (sv) 1989-10-02
FR2513126A1 (fr) 1983-03-25
NZ201682A (en) 1985-08-16
GB2104382B (en) 1984-12-19
JPS5846024A (ja) 1983-03-17
MW3882A1 (en) 1984-07-11
IT8223017A0 (it) 1982-08-27
DE3232034C2 (fr) 1991-04-11
SE8204873L (sv) 1983-02-28
NL192192B (nl) 1996-11-01
AU8759482A (en) 1983-03-03
CA1176158A (fr) 1984-10-16
IE822064L (en) 1983-02-27
DZ452A1 (fr) 2004-09-13
AU551879B2 (en) 1986-05-15
IT1153182B (it) 1987-01-14
DE3232034A1 (de) 1983-03-10
ZW17482A1 (en) 1982-11-17
IE54119B1 (en) 1989-06-21
LU84359A1 (fr) 1983-02-28
ZA826159B (en) 1984-04-25
GB2104382A (en) 1983-03-09
SE8204873D0 (sv) 1982-08-25
FR2513126B1 (fr) 1986-04-18
PH19361A (en) 1986-04-02
BE894185A (fr) 1983-02-24
NL8203315A (nl) 1983-03-16
IL66611A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
NL192192C (nl) Farmaceutische preparaten, die menselijk insuline en menselijk C-peptide bevatten.
AU624595B2 (en) Method for treating and preventing secondary effects of hyperinsulinemia and for treating type 2 diabetes, obesity and hyperlipidemia by application of insulin-like growth factor (IGF I)
US7476388B2 (en) Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand
US7312196B2 (en) Formulations for amylin agonist peptides
JP4212240B2 (ja) 肺送達のための安定に濃縮されたインスリン製剤
JP2005526126A (ja) インスリンアスパルト及びインスリンデテミアを含む可溶性製剤
AU2002243501A1 (en) Composition for inducing islet neogenesis, containing gastrin/CCK receptor ligands and EGF receptor ligands
US5939387A (en) Method of treating insulin resistance
JP2012233003A (ja) 単量体インスリン及びアシル化インスリンを含む可溶性製剤
EP0613376B1 (fr) Utilisation du igf-1
CA1176161A (fr) Composes pharmaceutiques contenant de l'insuline humaine et de la proinsuline
US4654324A (en) Human proinsulin pharmaceutical formulations
WO2008091177A1 (fr) Médicament pour le traitement du diabète à base d'exenatide et de dalargine, utilisation et traitement
CA1176160A (fr) Compose pharmaceutique de pro-insuline humaine
JP2007519669A (ja) 脂肪異栄養症を治療するための方法及び組成物
CA1176159A (fr) Compose pharmaceutique contenant de l'insuline humaine, un c-peptide et de la pro-insuline

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020824